Explore INA’s Partnerships

Norfund is the Norwegian Investment Fund for developing countries, with a mission to create jobs and improve lives by investing in businesses that drive sustainable development. As the Norwegian Government’s most important tool for strengthening the private sector in developing countries and reducing poverty, it is fully owned and funded by the government.

SK Plasma, a subsidiary of the SK Group, one of South Korea's largest conglomerates with a global presence, is a leader in the fields of biologics and pharmaceutical therapies. With a solid track record in world-class manufacturing, globally certified production facilities, and extensive expertise in plasma therapies through dedicated research and development efforts, SK Plasma stands at the forefront of its industry.

Changzhou Liyuan, a subsidiary of Jiangsu LOPAL Tech. Co., Ltd. (“LOPAL Tech”, SHSE: 603906), dedicated to the development, production and marketing of LFP (Lithium Ferro Phosphate). Until now, Changzhou Liyuan is the fastest growing LFP cathode materials players among global top 3 and the 1st to achieve global production and global customer base.

The Australian Embassy represents the Australian Government in Indonesia. It is the largest of Australians overseas diplomatic missions. Embassy staff deal with a range of matters, including trade, diplomatic relations, two-way investment, education, defence and security cooperation and development partnerships.

Development Bank of Japan Inc. (“DBJ”) is a 100% government-owned financial institution headquartered in Tokyo, Japan. DBJ provides domestic and global financial services to its clients, operating across Japan, the U.S., Europe, and Asia, with a mission to “Design the Future with Financial Expertise”, and ultimately pursue sustainable development for Japan and the world.

The Nusantara Capital Authority (NCA) is the authority responsible for managing and regulating Nusantara. NCA is an institution equivalent to a ministry established by the Government of Indonesia, operating directly under the President of the Republic of Indonesia. NCA's duties include supporting the preparation, development, and relocation of the national capital to Nusantara.

Pollination is a specialist climate change investment and advisory firm, accelerating the transition to a net zero, nature positive future.

The U.S. International Development Finance Corporation (DFC) is America’s development finance institution. DFC partners with the private sector to finance solutions to the most critical challenges facing the developing world.

BII is the UK’s development finance institution and impact investor, with a focus on investing in sustainable development by supporting companies that help developing and emerging countries grow.

IFU is a Danish independent government-owned fund offering risk capital to companies in developing countries and emerging markets, focusing on contributing to the green transition as well as economic and social development.

DP World is a multinational logistics company based in Dubai, United Arab Emirates. It specialises in cargo logistics, port terminal operations, maritime services and free trade zones.

Masdar is one of the world’s largest renewable energy companies and a green hydrogen leader, with the Abu Dhabi National Oil Company (ADNOC), Mubadala Investment Company, and Abu Dhabi National Energy Company PJSC (TAQA) as its shareholders.

CEXIM is a state-funded and state-owned policy bank with the status of an independent legal entity, dedicated to supporting China’s foreign trade, investment and international economic cooperation.

GDS is the leading vertically integrated provider of high performance data center and IT infrastructure services in China and South East Asia.

ESR Group is Asia Pacific's largest real asset manager powered by the New Economy and the third largest listed real estate investment manager globally.

SK Plasma is a South Korean biopharmaceutical company specializing in the development and production of blood plasma products, utilizing plasma fractionation processes to separate different components of human plasma to produce a range of therapeutic proteins.

DBJ is a Japanese governmental bank that engages in financing, investment, consulting/advisory services, and asset management. Through its Growth & Cross-Border Investment arm, DBJ provides equity / mezzanine investment in companies outside Japan, especially in Southeast Asia.